Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Dose-Finding Clinical Trial of CARDIOsphere® (PB127) in Normal Volunteers and in Patients With Known or Suspected Coronary Artery Disease

NCT00584818 is registered in ClinicalTrials.gov with Point Biomedical as lead sponsor.

NCT NCT00584818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00584818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Dose-Finding Clinical Trial of CARDIOsphere® (PB127) in Normal Volunteers and in Patients With Known or Suspected Coronary Artery Disease
Lead sponsor
Point Biomedical
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
March 31, 2008
Enrollment
205 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, healthy